抑制PERK可抑制缺血性视网膜病变中的新生血管形成并保护神经元
本研究在小鼠氧诱导视网膜病变(OIR)模型中探索PERK的作用,用选择性PERK抑制剂GSK2606414口服干预。结果显示PERK磷酸化在OIR视网膜中明显升高,抑制PERK可显著减少视网膜新生血管和视网膜神经节细胞丢失、恢复星形胶质细胞网络并促进血管再通,同时下调单核吞噬细胞的募集/增殖而不影响经典促血管生成通路。
要点
- OIR视网膜中PERK磷酸化明显升高,口服GSK2606414可抑制该磷酸化。
- 抑制PERK显著减少视网膜新生血管和视网膜神经节细胞丢失,恢复星形胶质细胞网络并促进血管再通。
- 抑制PERK下调单核吞噬细胞募集/增殖,但未影响OIR上调的经典促血管生成通路。
核心结论
- 结果表明PERK参与缺血诱导的视网膜病变,用GSK2606414抑制PERK可能提供一种旨在减轻视网膜新生血管同时防止视网膜缺血期间神经元丢失的有效治疗干预。
研究设计与样本
- 研究采用小鼠氧诱导视网膜病变(OIR)模型,新生幼鼠于出生后第7天(P7)暴露于70%氧气,P12返回室内空气以诱导OIR。
- GSK2606414为选择性PERK抑制剂,幼鼠返回室内空气后立即开始每日一次口服给药,直至样本采集前1天。
- 采用蛋白质印迹、免疫染色和定量PCR评估PERK磷酸化、视网膜改变及与PERK抑制相关的信号通路。
主要发现
- OIR视网膜中PERK磷酸化明显升高,GSK2606414可抑制该磷酸化。
- 抑制PERK显著减少视网膜新生血管和视网膜神经节细胞丢失,恢复星形胶质细胞网络并促进血管再通。
- 抑制PERK下调单核吞噬细胞的募集/增殖,但未影响OIR上调的经典促血管生成通路。
局限性
- 原文未报告局限性。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
PURPOSE: Retinal ischemia is a common cause of a variety of eye diseases, such as retinopathy of prematurity, diabetic retinopathy, and vein occlusion. Protein kinase RNA-activated-like endoplasmic reticulum (ER) kinase (PERK), one of the main ER stress sensor proteins, has been involved in many diseases. In this study, we investigated the role of PERK in ischemia-induced retinopathy using a mouse model of oxygen-induced retinopathy (OIR). METHODS: OIR was induced by subjecting neonatal pups to 70% oxygen at postnatal day 7 (P7) followed by returning to room air at P12. GSK2606414, a selective PERK inhibitor, was orally administrated to pups right after they were returned to room air once daily until 1 day before sample collection. Western blot, immunostaining, and quantitative PCR were used to assess PERK phosphorylation, retinal changes, and signaling pathways in relation to PERK inhibition. RESULTS: PERK phosphorylation was prominently increased in OIR retinas, which was inhibited by GSK2606414. Concomitantly, PERK inhibition significantly reduced retinal neovascularization (NV) and retinal ganglion cell (RGC) loss, restored astrocyte network, and promoted revascularization. Furthermore, PERK inhibition downregulated the recruitment/proliferation of mononuclear phagocytes but did not affect OIR-upregulated canonical angiogenic pathways. CONCLUSIONS: Our results demonstrate that PERK is involved in ischemia-induced retinopathy and its inhibition using GSK2606414 could offer an effective therapeutic intervention aimed at alleviating retinal NV while preventing neuron loss during retinal ischemia.
引用
- Shi S, Ding C, Zhu S, et al. PERK Inhibition Suppresses Neovascularization and Protects Neurons During Ischemia-Induced Retinopathy. Invest Ophthalmol Vis Sci. 2023. PMID: 37566408. doi:10.1167/iovs.64.11.17
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。